Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
Review: CUSABIO\'s protein products have excellent activity data and purity, and their protocols are comprehensive. The service is also very good. Our experiments have been very successful, and the antibodies we screened have good specificity and high sensitivity. We will continue to purchase from CUSABIO in the future!
Review: I used the CSB-MP001627RA product to develop a competitive ELISA method, and the results showed that the protein had good binding activity, stable properties, and excellent repeatability, and all parameter indicators met the standards. It is a repeat purchase, and I will continue to purchase this product.
Review: The protein has seven transmembrane domains, making it very difficult for recombinant expression. I have purchased both of CUSABIO\'s mammalian cell and cell-free expressed products, and they have performed well in terms of activity determination, which are sufficient to meet my future application demands. I may continue to purchase in large quantities in the future.
Review: I used the CSB-MP003996HU protein for an ELISA experiment, and the EC50 was measured to be 0.8830-2.771 ng/ml, indicating good protein activity. In the subsequent antibody screening, we employed flow cytometric analysis to determine whether this protein can bind to molecules expressed on the cell surface. The results showed that some antibodies were able to bind to this protein. The protein quality is quite good.
Review: I used the CSB-MP004900HU protein with an anti-CD22 rabbit monoclonal antibody for an ELISA experiment, and the EC50 was measured to be 0.8979-1.508 ng/ml, indicating good protein activity. CUSABIO has rich experience in protein expression, and protein products have good activity and stable properties, providing great convenience and assistance for our research!
Review: CCR8 is a multi-pass transmembrane protein, and expressing only its extracellular domain can disrupt its conformational epitopes, resulting in the loss of some antigenic epitopes. Your company has developed this full-length protein with good biological activity and immunogenicity. It will be very helpful for our company\'s subsequent development of antibody drugs.
